Bill

Bill > SB031


CO SB031

CO SB031
Use of Prescription Product with Controlled Substance


summary

Introduced
01/22/2026
In Committee
02/12/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is: ! Approved for prescription use by the United States food and drug administration; and ! Designated or rescheduled by the United States drug enforcement agency (DEA). The exemption applies upon the DEA's designation or rescheduling. The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.

AI Summary

This bill exempts certain prescription drug products containing a controlled substance that is normally classified as Schedule I, meaning it has a high potential for abuse and no currently accepted medical use, from this strict classification in Colorado. Specifically, if a prescription drug product is approved for medical use by the U.S. Food and Drug Administration (FDA) and is then reclassified or designated by the U.S. Drug Enforcement Administration (DEA) to a schedule other than Schedule I, or is otherwise exempted by federal regulations, it will also be exempt from Colorado's Schedule I classification. The bill ensures that these products will be regulated in Colorado in the same way they are regulated by the DEA, and their rescheduling in Colorado will automatically happen when the DEA makes its federal change. This aims to allow healthcare professionals in Colorado to prescribe and use FDA-approved medications that have been reclassified by the DEA, while still maintaining appropriate controls. The bill also clarifies that this exemption does not apply to natural medicines or products regulated under specific other Colorado laws.

Committee Categories

Health and Social Services

Sponsors (4)

Last Action

Senate Third Reading Calendar (07:30:00 2/24/2026 Senate Floor) (on 02/24/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...